CAS 83915-83-7

Lisinopril dihidrato

Descripción:

Lisinopril dihidrato es un inhibidor de la enzima convertidora de angiotensina (ECA) que se utiliza principalmente en el tratamiento de la hipertensión y la insuficiencia cardíaca. Es un polvo cristalino blanco a blanco amarillento que es soluble en agua, lo que facilita su absorción en el cuerpo. La fórmula química de Lisinopril dihidrato refleja su forma de dihidrato, indicando la presencia de dos moléculas de agua asociadas con cada molécula de lisinopril. Este compuesto actúa inhibiendo la conversión de angiotensina I a angiotensina II, lo que lleva a la vasodilatación y a la reducción de la presión arterial. Lisinopril dihidrato se administra típicamente por vía oral y es conocido por su larga vida media, lo que permite una dosificación una vez al día. Los efectos secundarios comunes pueden incluir mareos, dolor de cabeza y trastornos gastrointestinales, mientras que los efectos adversos graves pueden involucrar deterioro renal e hiperkalemia. Al igual que con cualquier medicamento, es esencial monitorear a los pacientes por posibles interacciones con otros fármacos y condiciones de salud subyacentes. En general, Lisinopril dihidrato es un medicamento ampliamente utilizado y efectivo en el manejo de enfermedades cardiovasculares.

Fórmula: C₂₁H₃₁N₃O₅·2H₂O

InChI: InChI=1S/C21H31N3O5.2H2O/c22-13-5-4-9-16(19(25)24-14-6-10-18(24)21(28)29)23-17(20(26)27)12-11-15-7-2-1-3-8-15;;/h1-3,7-8,16-18,23H,4-6,9-14,22H2,(H,26,27)(H,28,29);2*1H2/t16-,17-,18-;;/m0../s1

Clave InChI: InChIKey=CZRQXSDBMCMPNJ-ZUIPZQNBSA-N

SMILES: C([C@@H](N[C@@H](CCC1=CC=CC=C1)C(O)=O)CCCCN)(=O)N2[C@H](C(O)=O)CCC2.O

Sinónimos:

• N~2~-(1-carboxy-3-phenylpropyl)-L-lysyl-L-proline dihydrate
• N-[2-[4-[[[(Cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]5-methylpyrazinecarboxamide dihydrate
• N~2~-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline dihydrate
• L-Proline, N2-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-, dihydrate
• Lisinopril dihydrate
• L-Proline, N2-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-, hydrate (1:2)
• L-Proline, 1-[N2-(1-carboxy-3-phenylpropyl)-L-lysyl]-, dihydrate, (S)-

Lisinopril Dihydrate

CAS: 83915-83-7

Fórmula: C₂₁H₃₁O₅N₃·2H₂O

Pureza: >98.0%(T)

Forma y color: White to Almost white powder to crystal

Peso molecular: 441.53

Ref: 3B-L0220

LISINOPRIL FOR PEAK IDENTIFICATION CRS

CAS: 83915-83-7

LISINOPRIL FOR PEAK IDENTIFICATION CRS

Ref: 41-Y0001701

LISINOPRIL DIHYDRATE CRS

CAS: 83915-83-7

LISINOPRIL DIHYDRATE CRS

Fórmula: C₂₁H₃₅N₃O₇

Forma y color: Powder

Peso molecular: 441.5185

Ref: 41-L0702000

Lisinopril dihydrate

CAS: 83915-83-7

Lisinopril dihydrate

Fórmula: C₂₁H₃₁N₃O₅

Pureza: 91.5%

Forma y color: White

Peso molecular: 405.22637

Ref: 47-695

LISINOPRIL FOR SYSTEM SUITABILITY A CRS

CAS: 83915-83-7

LISINOPRIL FOR SYSTEM SUITABILITY A CRS

Forma y color: Powder

Ref: 41-Y0001709

Lisinopril

CAS: 83915-83-7

Cardiovascular drugs, not elsewhere specified or includ

Fórmula: C₂₁H₃₁N₃O₅·2H₂O

Forma y color: White Off-White Powder

Peso molecular: 405.22637

Ref: 45-1368609

L-Proline, N2-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-, hydrate (1:2)

CAS: 83915-83-7

Fórmula: C₂₁H₃₅N₃O₇

Pureza: 99%

Forma y color: Solid

Peso molecular: 441.5185

Ref: IN-DA003RAL

Lisinopril dihydrate, 10mM (in H2O)

CAS: 83915-83-7

Lisinopril dihydrate, 10mM (in H2O)

Fórmula: C₂₁H₃₅N₃O₇

Pureza: ≥98%, 10 mM in H2O

Peso molecular: 441.52

Ref: 54-BUP19973

Lisinopril dihydrate

CAS: 83915-83-7

Lisinopril dihydrate （MK-521) is an orally bioavailable, long-acting angiotensin-converting enzyme (ACE) inhibitor with antihypertensive activity.

Fórmula: C₂₁H₃₅N₃O₇

Pureza: 98.83% - 99.22%

Forma y color: White To Off-White Crystalline Powder

Peso molecular: 441.52

Ref: TM-T0706

Lisinopril

CAS: 83915-83-7

Fórmula: C₂₁H₃₁O₅N₃·2H₂O

Pureza: (Titration) 98.0 - 102.0 % (anhydrous basis)

Forma y color: White to almost white crystalline powder

Peso molecular: 441.52

Ref: 7W-GP1712

Lisinopril dihydrate

CAS: 83915-83-7

Lisinopril dihydrate

Pureza: ≥98%

Peso molecular: 441.52g/mol

Ref: 54-BUP18385

Lisinopril dihydrate

Producto controlado

CAS: 83915-83-7

Fórmula: C₂₁H₃₁N₃O₅H₂O

Forma y color: Neat

Peso molecular: 441.52

Ref: 04-C14640500

Lisinopril Dihydrate

CAS: 83915-83-7

Forma y color: Neat

Ref: 61-FOR0598.00

Lisinopril Dihydrate

Producto controlado

CAS: 83915-83-7

Fórmula: C₂₁H₃₁N₃O₅H₂O

Forma y color: Neat

Peso molecular: 441.52

Ref: 86-MM0598.00

Lisinopril Dihydrate

CAS: 83915-83-7

Fórmula: C₂₁H₃₁N₃O₅(H₂O)

Peso molecular: 405.5 : 2(18.0)

Ref: ST-EA-CP-L21000

(S)-Lisinopril Dihydrate

CAS: 83915-83-7

Stability Hygroscopic
Applications An orally active angiotensin-converting enzyme (ACE) inhibitor. S,S,S-Isomer of Lisinopril.
References Goa, K.L., et al.: Drugs, 52, 564 (1996), Chaturvedi, N., et al.: Lancet, 351, 28 (1998)

Fórmula: C₂₁H₃₁N₃O₅·2H₂O

Forma y color: Neat

Peso molecular: 441.52

Ref: TR-L468985

LISINOPRIL DIHYDRATE

CAS: 83915-83-7

Pureza: 99%

Peso molecular: 441.5249939

Ref: 10-F817920

2-Deoxy-3,4,6-tri-O-pivaloyl-D-glucopyranosyl azide

CAS: 83915-83-7

2-Deoxy-3,4,6-tri-O-pivaloyl-D-glucopyranosyl azide is a drug that regulates the blood pressure. It is an oral hypoglycaemic agent that has been shown to lower blood sugar levels in patients with type 2 diabetes mellitus. The drug is metabolized in the liver by cytochrome p450 enzymes and can cause interactions with drugs such as lisinopril, which are metabolized by these enzymes. 2DGPA has been shown to be effective at lowering blood pressure in a low-dose group of patients with essential hypertension. The signal peptide sequence was detected in the protein sequencing of a biological sample from rats treated with 2DGPA. This drug also reduces natriuretic peptide levels and has a rate constant of 4s−1M−1s−1.

Fórmula: C₂₁H₃₅N₃O₇

Pureza: Min. 95%

Peso molecular: 441.53 g/mol

Ref: 3D-MD08483